期刊文献+

中药红景天对肝组织中ALRmRNA的影响及可能的抗纤机制探讨 被引量:2

The changes of ALRmRNA by Chinese Rhodiola Sachalinensis A Bor and the protective mechanism on liver fibrosis
下载PDF
导出
摘要 目的从分子水平探讨中药红景天抗肝纤维化的疗效及可能抗纤机制。方法Wistar大鼠90只雌雄各半,随机等分三组:空白组、模型组和红景天组。以CCL4造模,用中药红景天灌胃进行治疗干预。检测肝组织中ALR mRNA(肝再生增长因子mRNA)表达量及组织病理情况,组织切片采用HE染色和VG染色。结果ALR mRNA的表达增强,红景天组与对照组比较两者有显著性差异(P<0.05)。肝组织病理学变化观察中药红景天组都在不同程度上缓解、逆转了肝纤维化的病变程度。结论中药红景天能显著通过促进ALR mRNA的表达可延缓或减轻肝硬化的发生。 Objective To study the molecular mechanism of treatment by Chinese herbs on the hepatic fibrosis of rats, Methods Hepatic fibrosis model of rats was established with CCIA. Then the rats were divided into control, model and Chinese herbs treated groups. The level of ALR mRNA expression and hepatic fibrosis parameters were observed from different groups. Results The level of ALR mRNA expression both in Chinese herbs treated group and model group were significantly higher than that in con- trol group ( P 〈 0.05 ). After treatment by Chinese herbs, the level of ALR mRNA expression in liver tissues was higher than that of control group ( P 〈 0. 05 ). Conclusions Our Chinese herbs significantly enhanced the ALR mRNA expression in liver of hepatic fibrosis rats.
出处 《实用肿瘤学杂志》 CAS 2008年第2期108-109,145,共3页 Practical Oncology Journal
关键词 中药红景天 肝纤维化 ALRmRNA Rhodiola Sachalinensis ABor Hepatic fibrosis ALRmRNA
  • 相关文献

参考文献6

二级参考文献44

共引文献189

同被引文献30

  • 1彭瑞云,王德文,高亚兵,杨瑞彪,刘萍,王芝萍,李延平,白蕴红,王晓民,熊呈琦,谢国良,徐在海.肥大细胞在放射性肝纤维化中的改变与作用的研究[J].中华放射医学与防护杂志,1994,14(1):29-32. 被引量:8
  • 2Nishmura SL. Integrin-mediated transforming growth factor- beta activation, a potential therapeucic target in fibrogenic disorders [J]. Am J Pathol, 2009, 175(4): 1362-1370.
  • 3Parsons C J, Takashima M, Rippe RA. Molecular mechanismsof hepatic fibmgenesis [J]. J Gastroen Hepatol, 2007, 22:79-84.
  • 4Baucer M, Schuppan D. TGF-beta 1 in liver fibrosis: time to change paradigms? [J]. FEBS Lett, 2001, 502(1-2): 1-3.
  • 5Takayama S, Hatori M, Kunhara Y, et al. Inhibition of TGF- betal suppresses motility and invasiveness of oral squamous cell carcinoma cell fines via modulation of integrins and down- regulation of matrix-metallopteinascs [J]. Oncol Rep, 2009, 21(1):205-210.
  • 6王若峥,张国庆.肿瘤放射治疗学[M].北京:科学出版社,2009.
  • 7Savage C, Das P, Finelli AL, et al. Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor 13 pathway components [J]. ProcNatl Acad Sci USA, 1996, 93(2):790-794.
  • 8Bai S, Cao X. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor beta signaling [J]. J Biol Chem, 2002, 277(6):4176-4182.
  • 9Roberts AB, Russo A, Felici A, et al. Smad3 a key player in pathogonetic mechanisms dependment on TGF-β [J]. Ann NY Acad Sci, 2003, 995:1-10.
  • 10Liu C, Gaca MD, Swenson ES, et al. Smad2 and Smad3 are differentially activated by transforming growth factor-13 (TGF- β) in quiescent and activated hepatic stellate cells[J]. J Biol Chem, 2003, 278(13): 11721-11728.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部